Patents
Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
05/2004
05/26/2004EP1420780A2 Cyclopropyl and cyclobutyl epothilone analogs
05/26/2004CN1151144C Benzopyans and benzothiopyrans as RAR selective retinoid agonists
05/21/2004WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
05/21/2004CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
05/20/2004US20040097699 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
05/19/2004CN1496999A Solid phase synthesing method of aldehyde, ketonic, oxime amine and isohydroximic acid compound
05/19/2004CN1496985A Preparation method of e-caprolactone
05/13/2004WO2004039773A2 Coumpounds modulating the activity of gapdh and/or iamt
05/12/2004EP1417197A1 Fungicidal 1-benzoxepin derivatives
05/12/2004EP1097128B1 Imidamide derivatives
05/11/2004US6734209 Synthetic salicylihalamides, apicularens and derivatives thereof
05/11/2004CA2099569C New a83543 compounds and process for production thereof
05/06/2004WO2003084482A3 Antidepressants and their analogues as long-acting local anesthetics and analgesics
05/06/2004US20040087804 Process for producing epsilon-caprolactone
05/06/2004US20040087634 Antitumor agents; plant safening agents
05/06/2004EP1414384A2 Synthesis of epothilones and relates analogs
05/06/2004EP0889042B1 Radicicol derivatives
04/2004
04/29/2004WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
04/28/2004EP1413342A1 Process for producing epsilon-caprolactone
04/28/2004EP1412346A1 Method for producing novel spinosyn derivatives
04/22/2004WO2004033702A1 Novel k99-5278 substances and process for producing the same
04/22/2004CA2463722A1 Novel k99-5278 substance and a process for production thereof
04/20/2004US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent
04/20/2004US6723731 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
04/15/2004WO2004031166A1 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof
04/15/2004WO2004030440A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins
04/15/2004CA2500056A1 Synthesis of oligomeric epicatechin and catechin-derived procyanidins
04/14/2004CN1489583A Novel physiologically active substance
04/14/2004CN1145621C Aromatic cyclic polyketone oligomer and its preparing method
04/07/2004EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels
04/07/2004EP1404663A1 Eurotinone and derivatives thereof, method for the production and use of the same
04/06/2004US6716832 Arylphenyl-substituted cyclic ketoenols
04/01/2004WO2003088927A3 Novel curcumin analogues and uses thereof
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
04/01/2004US20040063778 Compounds having improved stability over that of natural benzolactones, and a process for synthesizing them; anticancer activity and inhibit V-ATPase activity
04/01/2004US20040063669 Alpha-phenyl-beta-ketosulfone
04/01/2004DE10243668A1 Verfahren zur Herstellung von makrocyclischen Ketonen und Lactonen A process for the preparation of macrocyclic ketones and lactones
03/2004
03/31/2004EP1401575A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts
03/30/2004US6713036 Mixing feed stream and oxidant using small scale multilamination mixing to yield reactant stream having characteristic mixing time; reacting with characteristic reaction time in reaction zone in presence of catalyst
03/25/2004WO2004024142A1 Hsp90 FAMILY PROTEIN INHIBITORS
03/25/2004WO2004024141A1 Hsp90 FAMILY PROTEIN INHIBITORS
03/25/2004WO2003060852A3 Catalytic osmium-assisted oxidative cleavage of olefins
03/25/2004US20040059145 Heterodiamondoids
03/24/2004EP1400505A1 Process for the preparation of macrocyclic ketones and lactones
03/24/2004CN1142923C 12,13-modified epothilone derivatives
03/23/2004US6710208 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and α,β-unsaturated carboxylic acid and aldehyde compounds
03/23/2004US6710073 Drugs that induce long term potentiation (ltp) and enhance cognitive function in mammals
03/18/2004WO2004022552A1 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
03/18/2004US20040053990 Radicicol derivatives
03/16/2004CA2096460C Dual action inhibitors
03/11/2004WO2004019879A2 Motilide compounds
03/11/2004WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
03/04/2004US20040044221 Anticancer ganets; drug resistance
03/03/2004EP1393800A1 Catalyst for carboxylic ester production and process for producing carboxylic ester
03/02/2004US6700013 O-bromophenylacetic acid derivative chemical intermediate; smooth muscle relaxants, antiinflammatory agents; respiratory system disorders
02/2004
02/26/2004US20040039026 Macromolecules such as (12R,13S,15S)-cyclopropyl 5-methyl-pyridine epothilone A, used as tubulin polymerization promoters and for cytolysis cancer cells; antiproliferative agents
02/19/2004WO2002030356A3 Synthesis of epothilones and relates analogs
02/12/2004WO2002094196A3 Method of treatment for cancers associated with elevated
02/12/2004US20040030194 Reacting hydrogen peroxide with 1-hydroperoxy-oxabicyclo(4.10.0)hexadecane in presence of copper catalyst
02/05/2004WO2004011661A1 Novel physiologically active substances
02/05/2004WO2003057204A3 Modulation of iamt (pimt or pcmt) in immune system
02/05/2004DE10232094A1 5-Thiaepothilone und 15-disubstituierte Epothilone 5-Thiaepothilone and 15-disubstituted epothilones
02/04/2004EP1386922A2 Synthesis of epothilones, intermediates thereof, analogues and uses thereof
02/04/2004EP1385837A1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
01/2004
01/29/2004WO2004009603A1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods
01/29/2004WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
01/29/2004WO2004009577A1 Heterodiamondoids
01/29/2004US20040019089 Multidrug resistant cell inhibitors; anticancer agents
01/29/2004US20040018598 Chemical intermediate for discodermolide, epothilone
01/29/2004CA2492857A1 Heterodiamondoids
01/28/2004CN1471536A Chemokine receptor antagonsis and method of use thereof
01/28/2004CN1136207C Catalyst for preparing lactone and process for preparing lactone
01/27/2004US6683111 Such as 2-ethoxy-3-(4-(2-xanthen-9-ylidene-ethoxy)-phenyl)-propionic acid; for treating conditions associated with peroxisome proliferator-activated receptors; treatment of diabetes/obesity
01/22/2004WO2004007483A1 Novel macrocycles for the treatment of cancer diseases
01/22/2004WO2004007476A1 Gesellschaft für biotechnologische forschung mbh (gbf)
01/22/2004US20040015005 Esterification using hafnium catalyst
01/22/2004CA2491422A1 Novel macrocycles for the treatment of cancer diseases
01/21/2004EP1278738B1 The oxidation of ketones to esters using a tin substituted zeolite beta
01/20/2004US6680055 Polyketide macrolides; anticancer agents; suppressing inflammation
01/15/2004WO2004005311A1 Bafilomycin-like metabolite from a novel micromonospora species
01/15/2004DE10041198B4 Verfahren zur Herstellung makrocyclischer Ester A process for the preparation of macrocyclic esters
01/14/2004EP1380579A1 Novel physiologically active substances
01/14/2004CN1468211A Nitroso diphenylamine derivatives
01/14/2004CN1134444C Epothilone analog and medicine combination
01/14/2004CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same
01/08/2004DE10227483A1 Verfahren zur Herstellung von 11(12)-Pentadecen-15-oliden A process for the preparation of 11 (12) -pentadecen-15-olides
01/02/2004EP1375491A1 Process for the preparation of 11(12)-pentadecen-15-olides
01/02/2004EP1373245A1 Intermediates for producing spinosyns
12/2003
12/31/2003CN1132807C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
12/30/2003US6670385 α-phenyl-βketosulfone
12/25/2003US20030236200 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
12/11/2003WO2003032912A3 Treatment of cns disorders using cns target modulators
12/10/2003CN1130369C Synthetic modification to spinosyn compounds
12/09/2003US6660758 Epothilone analogs
12/04/2003WO2003099719A1 Microporous crystalline zeolite material (zeolite itq-22), synthesis method thereof and use of same as a catalyst
12/04/2003WO2002080846A3 Epothilone derivatives and methods for making and using the same
12/02/2003US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
11/2003
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003US20030220360 Tricyclic condensed heterocyclic compounds containing o, s in the ring, and atleast one hydroxy group, useful as antiasthmatic drugs
11/27/2003US20030220295 Epothilone derivatives
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 36